Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Tekla Capital Management
3145
Tekla Capital Management
Suggest edits
Follow us
Also headquartered in Boston
General Electric
DraftKings
Bain Capital
Sophia
TA Associates
Wikibon
Zipcar
State Street
Battery Ventures
Bolt
Overview
News
Investments
10
Portfolio
Portfolio Tracker
Add info
$65,000,000
Venture capital (Series B)
FinSMEs
HotSpot Therapeutics Closes $65M Series B Financing
Xconomy
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
$55,000,000
Venture capital (Series C)
Xconomy
Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic
Xconomy
With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite
$113,800,000
IPO
PE HUB
Biopharma firm Atreca goes public
FinSMEs
Pfizer Acquires Clinical-Stage Biotech Company Therachon, for Up To $810M
Silicon Canals
Swiss startup Oculis secures €13.8M funding to treat ophthalmic diseases
$15,711,870
Venture capital (Series B)
FinSMEs
,
PE HUB
Oculis Raises CHF15.5M in Extension of Series B Financing
$80,000,000
Venture capital
FinSMEs
Milestone Pharmaceuticals Raises $80M in Equity Funding
Funding
Health
$125,000,000
Venture capital (Series C)
FinSMEs
,
PE HUB
,
MedCity News
Atreca Raises $125M in Series C Funding
Funding
$60,000,000
Venture capital (Series B)
FinSMEs
Biotech Company Therachon Raises $60M Mezzanine Financing
Funding
Health
$45,000,000
Venture capital (Series A)
PE HUB
,
FinSMEs
HotSpot Therapeutics scores $45 mln Series A
Data leaks
Messaging
$20,000,000
Venture capital (Series B)
FinSMEs
BioClin Therapeutics Raises $20M; Completes $50M Series B Financing
Funding
Health
PE HUB
| Oculis nabs $20.3 mln Series B
Funding
Health
$20,300,000
Venture capital (Series B)
Norðurskautið
,
FinSMEs
Oculis raises $20.3m Series B round to advance treatment for Ophthalmic Diseases
Funding
Health
$35,000,000
Venture capital (Series B)
PE HUB
,
PE HUB
Atreca raises $35 mln Series B co-led by Wellington
Funding
$75,000,000
IPO
Xconomy
With $75M Haul, Ovid Continues Flurry of Biotech IPOs
Health
Science
$30,000,000
Venture capital (Series B)
PE HUB
,
Xconomy
BioClin Therapeutics inks $30 mln Series B
Messaging
Funding
Data leaks
$5,000,000
Venture capital (Series A)
Therachon
Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing
Venture capital (Series A)
Norðurskautið
Oculis Pharma raises Series A led by Brunnur Ventures and Silfurberg
Health
Funding
